Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells - PubMed (original) (raw)

doi: 10.1038/nm.1928. Epub 2009 Mar 1.

Affiliations

Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells

Chinnaswamy Jagannath et al. Nat Med. 2009 Mar.

Erratum in

Abstract

The variable efficacy of Bacille Calmette Guerin (BCG) vaccination against tuberculosis has prompted efforts to improve the vaccine. In this study, we used autophagy to enhance vaccine efficacy against tuberculosis in a mouse model. We examined the effect of autophagy on the processing of the immunodominant mycobacterial antigen Ag85B by antigen presenting cells (APCs), macrophages and dendritic cells (DCs). We found that rapamycin-induced autophagy enhanced Ag85B presentation by APCs infected with wild-type Mycobacterium tuberculosis H37Rv, H37Rv-derived DeltafbpA attenuated candidate vaccine or BCG. Furthermore, rapamycin enhanced localization of mycobacteria with autophagosomes and lysosomes. Rapamycin-enhanced antigen presentation was attenuated when autophagy was suppressed by 3-methyladenine or by small interfering RNA against beclin-1. Notably, mice immunized with rapamycin-treated DCs infected with either DeltafbpA or BCG showed enhanced T helper type 1-mediated protection when challenged with virulent Mycobacterium tuberculosis. Finally, overexpression of Ag85B in BCG induced autophagy in APCs and enhanced immunogenicity in mice, suggesting that vaccine efficacy can be enhanced by augmenting autophagy-mediated antigen presentation.

PubMed Disclaimer

References

    1. Infect Immun. 2004 May;72(5):2872-8 - PubMed
    1. Infect Immun. 1996 Aug;64(8):3038-47 - PubMed
    1. Traffic. 2003 Sep;4(9):600-6 - PubMed
    1. Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8841-8 - PubMed
    1. Cell Immunol. 2000 Apr 10;201(1):63-74 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources